Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family that plays a critical role in numerous neuronal activities. Recent studies have indicated that some functions or action mechanisms of BDNF vary in a sex-dependent manner. In particular, BDNF content in some brain parts and the tendency to develop BDNF deficiency-related diseases such as depression are greater in female animals. With the support of relevant studies, it has been suggested that sex hormones or steroids can modulate the activities of BDNF, which may account for its functional discrepancy in different sexes. Indeed, the cross-talk between BDNF and sex steroids has been detected for decades, and some sex steroids, such as estrogen, have a positive regulatory effect on BDNF expression and signaling. Thus, the sex of animal models that are used in studying the functions of BDNF is critical. This Mini-Review summarizes our current findings on the differences in expression, signaling, and functions of BDNF between sexes. We also discuss the potential mechanisms for mediating these differential responses, with a specific emphasis on sex steroids. By presenting and discussing these findings, we seek to encourage researchers to take sex influences into consideration when designing experiments, interpreting results, and drawing conclusions. V C 2016 Wiley Periodicals, Inc.
The central nervous system (CNS) is different in structure, activity, development, and chemistry in female compared with male mammals (Raznahan et al., 2010; Ruigrok et al., 2014; Forger et al., 2016) . Although these phenomena have long been recognized, the mechanism that causes the differences is still not clear (Cahill, 2006) . Some of the sex variations, nevertheless, could be explained by the different concentrations of gonadal steroids (androgens in male and estrogens in female), which are produced mainly in the testicles in male mammals and in the ovaries in female mammals. There are three natural estrogens, estrone, 17b-estradiol, and estriol in female mammals and one major androgen, testosterone, in male mammals. These hormones act on the brain via multiple mechanisms to shape the differences, and their actions rely partially on interaction with other factors/hormones, such as neurotrophins. Neurotrophins are growth factors that regulate numerous activities of the nervous system and consist of four members, nerve growth factor, brainderived neurotrophic factor (BDNF), neurotrophin 3 (NT-3) and NT-4/5. BDNF was the second neurotrophin identified and has the most abundant and widespread expression in both developing and mature mammalian brain (Cunha et al., 2010) . BDNF has been shown to be involved in every aspect of neuronal activity, including neuronal survival, neurogenesis, dendritic branching, SIGNIFICANCE Sex influence on brain function is now being spotlighted in the field of neuroscience. Although brain-derived neurotrophic factor (BDNF) plays a critical role in numerous neuronal activities, the effect of sex difference on BDNF activity has not been systemically studied or reviewed. This Mini-Review seeks to integrate the scattered findings on sex differences in BDNF research and discuss their potential effects on our understanding of BDNF's functions. neurotransmitter production and release, synapse formation and maturation, and synaptic plasticity, indicating that BDNF is crucial for the development and maintenance of the brain's activities (Park and Poo, 2013) . In addition to its contribution in normal brain functions, BDNF has been implicated in various neurological disorders. Lower concentration of BDNF in the blood stream or cerebral fluid has been correlated with the prognosis of Alzheimer's disease, Parkinson's disease, Huntington's diseases; Rett syndrome; and amyotrophic lateral sclerosis (Zuccato and Cattaneo, 2009) . In fact, administration of BDNF is effective in improving the neuronal deficits in a number of animal disease models, suggesting that BDNF is a potential therapeutic agent against various traumas such as stroke, spinal cord injury, and aging-related neuronal loss (Nagahara and Tuszynski, 2011) . However, the therapeutic effect of BDNF can be affected by many factors, including time and place of administration, age, and even sex of the recipients. The sex-specific effect on BDNF expression, signaling, and activity has not raised much concern in most of the BDNF-related research, and this may affect the analysis of BDNF's functions or activities. For instance, Li et al. (2010) demonstrated that BDNF injection can alleviate the acetic acid-induced pain response in male rats. In contrast, the pain-killing effect of BDNF was abolished when female rats were used in the examination. Thus, the conclusion drawn from an identical study may be completely different if a different sex is used in the research model. Because limited studies have been performed on this topic, the mechanism underlying how sex differences affect the physiological or therapeutic activity of BDNF is still unclear. This Mini-Review seeks to present the findings on how sex affects the expression, signaling, and functions of BDNF. The possible role of sex hormones in these differential activities is also discussed, and we close with a brief discussion of some problems that must be resolved in the future.
SEX DIFFERENCES IN CIRCULATING BDNF
AND BDNF EXPRESSION BDNF is produced mainly in the CNS and can be detected in almost every brain part (Conner et al., 1997; Katoh-Semba et al., 1997) . When the absolute amount of BDNF in various brain regions is compared between male and female rats, it is found that females have higher BDNF content in the hippocampus, ventromedial hypothalamus, cortex, and amygdala than males (Bland et al., 2005; Bakos et al., 2009; Snigdha et al., 2011; Liu et al., 2014) . Similarly, Franklin and Perrot-Sinal (2006) have demonstrated a lower level of BDNF in male hippocampus CA3 region. However, the authors also found that the dorsal dentate gyrus of the hippocampus in male rats had more BDNF compared with the same region in female rats. In contrast to rats, male mice have more BDNF in the hippocampus, cortex, and brainstem (Szapacs et al., 2004) . In humans there is no significant difference in hippocampal BDNF content between men and women, but female subjects have higher BDNF in the prefrontal cortex (Hayley et al., 2015) . Sex-dependent expression differences can also be detected in nonmammalian species. For example, male songbirds have a higher BDNF level in the high vocal center, which is believed to be an important factor in their singing behavior during mating (Rasika et al., 1999) . These reports suggest that sex differences in the CNS distribution of BDNF are consistent among various species. Nevertheless, these observations have been generated from fragmented and scattered studies that were not designed primarily to examine the tissue distribution of BDNF in different sexes. Thus, a systematic and comprehensive comparison of the sex-and species-specific BDNF expression in corresponding brain regions should be performed to clarify this issue.
In addition to basal transcription, stress-and stimulus-induced BDNF expression also shows significant sex-dependent variations. Compelling evidence of this disparity comes from investigations on the effect of environmental enrichment on brain functions, which has been shown to increase neuronal BDNF expression, probably by epigenetic modifications (Ickes et al., 2000; Kuzumaki et al., 2011; Vazquez-Sanroman et al., 2013) . Specifically, an enriched environment induces more BDNF expression in the prefrontal cortex, hippocampus, and hypothalamus of female mice (Zhu et al., 2006; Bakos et al., 2009 ). Chen et al. (2005) further demonstrated that environmental enrichment promotes BDNF expression only in the female brain after traumatic injury. Stressinduced responses are also different between male and female. An early stressful event such as isolation, early weaning, or mother deprivation decreases BDNF transcription only in the male hippocampus and hypothalamus (Kikusui et al., 2009; Viveros et al., 2010; Weintraub et al., 2010) . In contrast, these maltreatments cause a female-specific increase of BDNF expression in the amygdala (Hill et al., 2014) . In a recent study, Liu et al. (2014) demonstrated a downregulation of BDNF expression in the male ventromedial hypothalamus during fasting. This observation concurs with the function of BDNF as an anorexic factor to suppress appetite in the hypothalamus (Pelleymounter et al., 1995) , which may be associated with the food-intake behavioral change in response to food availability because male animals have higher foodanticipatory activity and food intake after refeeding (Li et al., 2015) . There is also a sex-specific response to pharmacologically stimulated BDNF expression in the brain. For example, the NMDA receptor antagonist dizocilpine increases BDNF expression in the cortex of female mice, whereas another NMDA receptor antagonist, phencyclidine, decreases BDNF expression in a variety of brain regions only in female rats (Matsuki et al., 2001; Snigdha et al., 2011) . In contrast, male brains are more responsive to the g-aminobutyric acid (GABA) receptor agonist diazepam and the cannabinoid agonist CP55940 in reducing hippocampal and hypothalamic BDNF expression (Kellogg et al., 2000; Lopez-Gallardo et al., 2012) . It remains to be explored whether sex-specific BDNF expression is responsible for efficacy of these receptor antagonists/agonists that display obvious sex-specific activities (Tseng and Craft, 2001; Feinstein and Kritzer, 2013) .
Although it has been suggested that most BDNF in the blood is released from the CNS (Rasmussen et al., 2009) , the differential BDNF expression in male and female brains does not cause divergence in circulating BDNF. Several studies have indicated comparable concentration of blood BDNF levels between men and women at various ages (Katoh-Semba et al., 2007; Ziegenhorn et al., 2007; Lang et al., 2009; Bus et al., 2012) . Presumably, the differences in neuronal BDNF expression affect only the autocrine or paracrine activity of BDNF. This autocrine theory is supported by another study performed in skeletal muscle. After electroporating plasmids that overexpress into the tibialis of mice, Matthews et al. (2009) found no increase of serum BDNF concentration in the tested mice, although BDNF content has increased 20-fold in their skeletal muscles. Nevertheless, the possibility that different platelet activities, the major reservoir of circulating BDNF (Fujimura et al., 2002) , may contribute significantly in normalizing the blood BDNF level in different sexes could not be excluded because the hormone uptake and aggregation activities of platelets are different between male and female (Halbreich et al., 1991; Haque et al., 2001 ).
SEX-SPECIFIC FUNCTIONS OF BDNF
Because of sex-specific expression in various conditions, it is expected that BDNF may induce different functions or different degrees of action in particular sexes. Comparative studies using male and female animals with ablated BDNF gene have provided some evidence to support this hypothesis. In one of these studies, it was shown that conditional deletion of BDNF gene in the forebrain (cKO) caused hyperactivity in male mice only. Female BDNF cKO mice, in contrast, displayed anxiety and depression behaviors, which could not be detected in male animals (Monteggia et al., 2007) . The observation that lower BDNF in female mouse brain causes depressive behaviors is an attractive explanation for the high preponderance of depression among women across cultures (Kuehner, 2003) . In support of this conclusion, a recent examination performed in post mortem samples from depressed women who died by suicide clearly demonstrated reduced BDNF levels within the frontopolar prefrontal cortex when compared with the nonpsychiatric controls (Hayley et al., 2015) . However, the linkage of BDNF level in the brain and depression has not been strongly established because another study that analyzed BDNF and its receptor tropomyosin kinase receptor B (TrkB) expression in post mortem subjects with major depressive disorder did not show any sex-dependent effect in the subgenual anterior cingulate cortex (Tripp et al., 2012) .
In contrast to depression behavior, heterozygous depletion of BDNF gene (BDNF 1/-) alleviates the anxiety behavior only in female serotonin (5-HT) transporter knockout (SERT -/-) mice (Ren-Patterson et al., 2006) . This study revealed that female SERT -/-BDNF 1/-mice had more 5-HT and its metabolite 5-hydroxyindoleacetic acid in their hippocampus and hypothalamus, elevated catecholamines (dopamine, dihydroxyphenylacetic acid, and homovanillic acid) in striatum, and augmented hypothalamic TrkB expression when compared with the SERT -/-
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1/1 mice. Because 5-HT concentration was observed in the hypothalamus of estradiol-implanted male mice, the authors suggested that the availability of estrogen protected female SERT -/-BDNF 1/-mice from monoamine depletion and thus reduced the anxiety behavior. In another study performed in neuron-specific BDNF knockout mice, Camerino et al. (2012) showed that ablation of BDNF in the CNS causes more body adiposity and higher bone mass in female animals. These phenotypes showed similarities close to those of the neuron-specific estrogen receptor knockout (ER -/-) mice (Ohlsson et al., 2012) . Thus, the authors postulated that BDNF and estrogen pathways may act synergistically in female mice to modulate the skeletal and metabolic phenotypes.
In a series of studies exploring the role of BDNF signaling in various disorders with our newly identified BDNF mimetic 7,8-dihydroxyflavone (7,8-DHF; Jang et al., 2010) , it was shown that this small molecule also displays selective pharmacological activities in different sexes. In the first study performed in mice with hypoxiaischemia (HI)-induced brain injury, 7,8-DHF-treatment showed a more pronounced protective effect against HIinduced hippocampal neurodegeneration and astrogliosis in female animals (Uluc et al., 2013) . A later study confirmed that 7,8-DHF treatment has a higher potency against HI-induced hippocampal apoptosis in female mice (Cikla et al., 2016) . This study also showed that the protective effect of 7,8-DHF is ablated in ER -/-animals. Having performed additional signaling analyses, the authors proposed that post-HI-induced ER expression in female hippocampus couples the c-Src kinase to augment TrkB phosphorylation and thereby reduces the cellular apoptosis and neuronal injury. Our recent study showed that 7,8-DHF initiates the AMPK/cAMP response element-binding (CREB)/uncoupling protein 1 pathway to increase lipid oxidation and energy expenditure in muscle cells (Chan et al., 2015) . In line with these in vitro findings, administration of 7,8-DHF increased the energy expenditure of mice under high-fat-diet (HFD) feeding, thus protecting these animals from gaining excess body weight. It is intriguing to note that the antiobesity function of 7,8-DHF could be detected only in female mice because HFD feeding induced similar body mass increase in both control and 7,8-DHF-treated male mice. Although the TrkB-ER cross-talk proposed by Cikla et al. (2016) provides an attractive model for explaining the sex-dimorphic activities of 7,8-DHF, we should also consider the fact that 7,8-DHF is an aromatase inhibitor (Chen et al., 1997; Kao et al., 1998) . Thus, additional studies on the role of 7,8-DHF in ER signaling and estrogen production are required to delineate the sexdependent activity of 7,8-DHF in both neurological system and peripheral tissues.
SEX-DEPENDENT SIGNALING INDUCED BY
BDNF BDNF exerts its biological actions via interaction with its cognate high-affinity receptor TrkB. After binding to the transmembrane receptor, BDNF induces TrkB dimerization and autophosphorylation. The phosphorylated residues in TrkB serve as the docking sites for adaptor proteins such as Src homology domain 2 or polypyrimidine tract-binding protein, leading to the activation of phosphoinositide 3-kinase-Akt, mitogen-activated protein kinase-extracellular signal-regulated kinase (ERK), and phospholipase Cg1-CREB signaling (Longo and Massa, 2013) . There is no clear evidence showing a sexual difference in BDNF-induced signaling under physiological conditions, but several indirect studies have suggested that female mice have a differential TrkB activation mechanism. Hill and van den Buuse (2011) demonstrated a sexdependent variation in TrkB signaling in BDNF 1/-mice. These authors reported that male BDNF 1/-mice exhibited greater TrkB phosphorylation than female animals in the frontal cortex and striatum. Consequently, the downstream ERK signaling was enhanced in the male BDNF 1/-brain. The mechanism that contributes to this differential TrkB signaling between male and female is unknown, but the authors suspect that steroids may a play significant role. In another study that investigated the distribution of phosphorylated (activated) TrkB in the hippocampus, Spencer-Segal et al. (2011) showed that the hippocampal CA1 region of proestrus females had more phosphorylated TrkB proteins than the age-matched males. In an earlier study, the same research group showed that TrkB and the downstream Akt phosphorylations fluctuated during the estrous cycle (Spencer et al., 2008) , further confirming that estrogen might increase TrkB signaling. Another elegant study seeking to explain the sex-specific pattern of mouse mammary gland development demonstrated that mammary mesenchymal cells expressed a high level of truncated TrkB isoform (TrkB-T1) in E13 male embryo in an androgen-dependent manner (Liu et al., 2012) . Thus, the BDNF generated by mesenchymal cells in male embryo is sequestered, leading to an inhibition of sensory neuron innervation to the mammary gland that eventually dampens the development of the mammary gland in male mice.
INTERACTION OF SEX HORMONES WITH
BDNF EXPRESSION AND SIGNALING The first link between BDNF and sex steroids was discovered in a study that showed a colocalization of BDNF and TrkB in the ER mRNA-containing neurons during forebrain development (Toran-Allerand et al., 1992) . Subsequent studies performed in animals with ovariectomy revealed that estrogen replacement increased BDNF expression in hippocampus, cortex, and olfactory bulb, confirming the BDNF-inducing activity of estrogen (Solum and Handa, 2002) . It is now generally accepted that estrogen modulates BDNF expression through at least four different mechanisms. First, estrogen directly induces BDNF expression via activating the ER. This conclusion is supported by the findings that BDNF gene contains a canonical estrogen response element (Sohrabji et al., 1995) , and gel shift and DNA footprinting assays clearly show that estrogen-ER complexes bind to this sequence (Sohrabji et al., 1995) . Second, estrogen modifies the activity of BDNF promoter epigenetically because ovariectomyinduced estrogen depletion causes an increase of methylation on BDNF promoters IV and V in the hippocampus (Moreno-Piovano et al., 2014) . The mechanism by which estrogen epigenetically controls BDNF expression is obscure but Fortress et al. (2014) recently reported that estradiol infusion into the hippocampus specifically increases histone H3 acetylation at BDNF promoters II and IV, possibly through decreasing the expression of histone deacetylase 2. Third, ER regulates the activity of CREB through nongenomic activity. In cultured hippocampalneurons, estradiol induces an influx of extracellular Ca 21 , leading to the activation of CREB (Zhao et al., 2005; Zhou et al., 2005) . Given that CREB is a major transcription factor that controls BDNF expression in neurons in response to Ca 21 concentration change (Shieh et al., 1998; Tao et al., 1998) , it is reasonable to conclude that the ER/ CREB axis may modulate the expression of BDNF (Fig.  1) . Finally, ER controls BDNF expression indirectly via interneuronal activity. Based on the results from immunofluorescent staining, Blurton-Jones and Tuszynski (2006) proposed that estrogen modulates BDNF expression in a cortical neuronal circuit that contains ERb-bearing neurons, non-ER-b-bearing GABA-ergic interneurons, and BDNF-producing neurons. In this model, estrogen increases GABA activity or production within the ERbbearing neurons, which inhibits the activity of non-ER-bbearing GABAergic interneurons. Because GABA is an inhibitory neurotransmitter of BDNF expression (Heese et al., 2000) , the reduced GABA production in the interneurons results in an elevation of BDNF transcription in the target cells. This model also provides a possible explanation for the observation that prenatal (gestation days [14] [15] [16] [17] [18] [19] [20] exposure to the GABA receptor agonist diazepam results in a male-specific reduction of BDNF expression in the hypothalamus (Kellogg et al., 2000) because female fetuses of the same gestational age have slightly higher estrogen levels in this region (Konkle and McCarthy, 2011) .
Compared with estrogen, the effect of androgen on BDNF expression has been less well studied. However, several studies have shown that testosterone, the major component of androgens, is a positive regulator of BDNF expression and production in the motor neurons of spinal nucleus of the bulbocavernosus, hippocampal CA1, and brain homogenate after middle cerebral artery occlusion (Osborne et al., 2007; Ottem et al., 2007; Li et al., 2012; Fanaei et al., 2014) . Progesterone, another important sex steroid produced mainly in the ovary, can also increase the production of BDNF in cortex explant and glial cells (Kaur et al., 2007; Su et al., 2012) . Interestingly, most studies showing the positive role of progesterone in BDNF expression have been performed in injured neurons, such as in spinal cord injury, traumatic brain injury, and ischemic stroke (Gonzalez et al., 2005; Cekic et al., 2012; Jiang et al., 2016) . From the results of these studies, it has been suggested that progesterone-mediated neuroprotection is BDNF dependent. Indeed, inhibition of TrkB activity by the kinase inhibitor K252a abolishes the protective effects of progesterone against glutamate-induced neurotoxicity (Kaur et al., 2007) . It has also been shown that progesterone attenuates estrogen-induced BDNF and TrkB expression, although both hormones are BDNF expression enhancers (Bimonte-Nelson et al., 2004; Aguirre and Baudry, 2009 ). The physiological significance of the contradictory effect of progesterone is unknown but these observations suggest that there is a complex interaction between sex-steroids to regulate BDNF expression.
Although the relationship between sex steroids and BDNF expression is evident, the interaction between steroid signaling and BDNF/TrkB pathway is largely unexplored. A recent study showed that overexpression of TrkB in Chinese hamster ovary cells induced transcription of ER-responsive element-containing reporter by increasing ERa phosphorylation through ERK (Wong et al., 2011) , which suggested that the BDNF/TrkB and ER signaling may somehow cross-talk with each other. However, this study did not provide any evidence on the endogenous protein association, which raises the concern of nonspecific interaction resulting from protein overexpression. Nevertheless, estrogen and BDNF trigger several common pathways, such as Akt, ERK, and in neurons (Belcher et al., 2005; Spencer-Segal et al., 2012) , which provides indirect evidence to support the TrkB-ER signaling cross-talk (Fig. 2) . Although no study has been performed to investigate whether these two factors provoke an additive or a synergistic effect in neurons, it has been proposed that estrogen-mediated synaptogenesis and neuroprotection occurs through BDNF release (KrizsanAgbas et al., 2003; Sato et al., 2007) . This hypothesis is supported by a study that used co-culture of uteri from wild-type (WT) or BDNF 2/2 mice with the rat sympathetic ganglia (Krizsan-Agbas et al., 2003) . In this study, the neuritogenesis induced by WT uteri was diminished in the presence of estrogen. However, neurite formation in the presence of BDNF -/-uteri was not affected by estrogen, indicating that estrogen alters the neuritogenic properties of the rodent uterus by regulating BDNF synthesis. Another study using BDNF 1/-mice demonstrated that estradiol replacement improved performance in the Y-maze and novel-object-recognition tests in ovariectomized WT but not in BDNF 1/-mice (Wu et al., 2015) . Thus, the integrity of BDNF/TrkB signaling is essential to some estrogen-mediated neurological action, but how these two pathways interact with each other remains mysterious.
CONCLUSIONS
It is now clear that sex differences under different physiological and pathological conditions are more widespread than had been assumed. The diversities in body weight and composition, hormonal status, and enzyme activity between male and female interact and contribute to these differences. Because most neuroscience research has been performed with animals of a single sex, our understanding of the sexual differences in neurological signaling, especially those induced by BDNF, is at an early stage, and most information that we have is fragmented and inconclusive. Many areas still require elucidation. An example is comparing whether BDNF initiates differential signaling cascades in males and females under physiological or pathological conditions. Because most studies were conducted to measure the functional outcome of BDNF administration in animals without elucidating the molecular mechanism or examining the cellular details, we do not have a clear picture of how BDNF causes the differential activities in different sexes. These data are critical for us to better assess the efficacy of employing BDNF therapy in human patients. Another unresolved question involves sex steroid-TrkB signaling cross-talk. It is essential to determine whether different sex steroids alter the signaling cascades induced by BDNF, in addition to their role in manipulating BDNF expression. Examining the functional effects of BDNF administration in animals lacking sex steroid receptors would provide some insights. Without a full understanding of the sex-specific effects, special care should be taken when interpreting the data from studies performed in either male or female animals to determine the overall activity of BDNF. This information is particularly important when translating the findings into BDNF-based therapeutic strategies in various neurodegenerative, psychiatric, and metabolic disorders. Therefore, determining and delineating the sex-specific activities of BDNF under both physiological and pathological conditions is highly warranted.
